GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Molecular Magnetic Resonance Imaging of Inflammation

$460,552
Eric Michael Gale · Massachusetts General Hospital · R01 · FY2023 · DK

Signaling circuits that drive cell movement and ligand scavenging by chemokine receptor CCR2

$460,395
Tracy M Handel · University Of California, San Diego · R01 · FY2023 · GM

Optimizing the Treatment of Pancreatic Adenocarcinoma

$460,388
Chin Hur · Columbia University Health Sciences · R01 · FY2020 · CA

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$460,385
Timothy Patrick Spicer · Scripps Florida · R33 · FY2018 · CA

University of Minnesota Clinical Center for the Study of Pancreatic Disease

$460,376
Melena D. Bellin · University Of Minnesota · U01 · FY2021 · DK

MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM

$460,342
Lewis C Cantley · Dana-Farber Cancer Inst · P01 · FY2011 · CA

Nanoscale Metal-organic Frameworks for Imaging and Therapy of Pancreatic Cancer

$460,295
Wenbin Lin · University Of Chicago · U01 · FY2013 · CA

Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer

$460,031
Andrea Viale · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Mitochondrial heterogeneity as the origin of chemoresistance in pancreatic cancer

$460,031
Andrea Viale · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer

$459,941
Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2023 · CA

A Fragment-Based Strategy for K-RAS Covalent Inhibitors

$459,832
Samy Meroueh · Indiana University Indianapolis · R01 · FY2022 · CA

A Fragment-Based Strategy for K-RAS Covalent Inhibitors

$459,832
Samy Meroueh · Indiana University Indianapolis · R01 · FY2023 · CA

Exploring Collateral Lethality for Development of Cancer Therapeutics

$459,831
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA

Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer

$459,799
Matteo Ligorio · Ut Southwestern Medical Center · R37 · FY2022 · CA

A novel miR-198 replacement therapy for pancreatic cancer

$459,697
Qizhi C. Yao · Baylor College Of Medicine · R01 · FY2019 · CA

Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease

$459,478
Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA

Role of the METTL13 Lysine Methyltransferase in Signaling and Cancer

$459,437
Or P. Gozani · Stanford University · R01 · FY2022 · CA

(PQD3)Molecular Profiles associated with Long-Term Survival in pancreas Cancer

$459,341
Nita Ahuja · Johns Hopkins University · R01 · FY2014 · CA

Pathophysiology, Epidemiology, and Prevention of Pancreatogenic Diabetes

$459,262
Stephen J Pandol · Cedars-Sinai Medical Center · U01 · FY2016 · DK

VEGF and PDGF in angiogenesis and tumor progression

$459,245
David A Cheresh · University Of California, San Diego · R37 · FY2012 · CA

Project 3: Transcriptomic subtypes, response predictions, and therapy selection

$459,209
Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA

UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer

$459,169
Andre Elias Nel · University Of California Los Angeles · U01 · FY2018 · CA

Molecular Magnetic Resonance Imaging of Inflammation

$459,160
Eric Michael Gale · Massachusetts General Hospital · R01 · FY2019 · DK

Matricellular proteins of the CNN family as regulators of tumor-induced cachexia

$458,823
Sarah M Judge · University Of Florida · R01 · FY2024 · CA

Machine learning accelerated on-line adaptive replanning

$458,806
Eric S Paulson · Medical College Of Wisconsin · R01 · FY2024 · CA